Yongsheng Liu

Uppsala University — Sweden

Medicine · Health Sciences

10h-index223citations25works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(16), Radiopharmaceutical Chemistry and Applications(14), HER2/EGFR in Cancer Research(5), DNA and Nucleic Acid Chemistry(2), Neuroblastoma Research and Treatments(2)

Publications25 total

Modular molecular and nuclear design of scaffold protein -mediated PNA-based radionuclide pre-targeting: application for DARPins
Nuclear Medicine and Biology·2025Open Access
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
Journal of Nuclear Medicine·2025· 1 cited
Development of terahertz bunker coal level radar for dynamic monitoring
2024· 1 cited
The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma
Journal of Experimental & Clinical Cancer Research·2024· 17 citedOpen Access
Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
European Journal of Nuclear Medicine and Molecular Imaging·2024· 9 citedOpen Access
Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker
Molecular Medicine Reports·2023· 2 citedOpen Access
CBD2: A functional biomarker database for colorectal cancer
iMeta·2023· 7 citedOpen Access
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Nuclear Medicine and Biology·2023· 11 citedOpen Access
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
Cancers·2023· 22 citedOpen Access
Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis
Pharmaceutics·2022· 7 citedOpen Access
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
Pharmaceutics·2022· 21 citedOpen Access
Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
Pharmaceutics·2022· 5 citedOpen Access
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
Pharmaceutics·2022· 15 citedOpen Access
Theranostic pairing: ABY-025/251 targeting HER2 with <sup>68</sup>Ga and <sup>188</sup>Re—Minimized radioligands using Affibody peptide scaffold technology.
Journal of Clinical Oncology·2022· 2 cited
Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071
Pharmaceutics·2022· 10 citedOpen Access
Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells
Oncology Reports·2022· 9 citedOpen Access
Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts
Journal of Nuclear Medicine·2021· 20 citedOpen Access
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
Cancers·2021· 17 citedOpen Access
Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
Pharmaceutics·2021· 15 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Vladimir Tolmachev(17), Anna Orlova(15), Anzhelika Vorobyeva(14), Tianqi Xu(13), Maryam Oroujeni(11), Fredrik Y. Frejd(8), Javad Garousi(5), Annika Loftenius(4), Vitalina Bodenko(4), Kristina Westerlund(4), Amelie Eriksson Karlström(4), Sara S. Rinne(4), Torbjörn Gräslund(4), Sergey M. Deyev(3), Alexey Schulga(3), Е. В. Коновалова(3), Eleftherios Papalanis(3), Ekaterina Bezverkhniaia(2), Evgenii Plotnikov(2), Ida Karlberg(2)